EP3997108A4 - Verfahren zur herstellung und verwendung von lipooligosaccharidzusammensetzungen und impfstoffen - Google Patents

Verfahren zur herstellung und verwendung von lipooligosaccharidzusammensetzungen und impfstoffen Download PDF

Info

Publication number
EP3997108A4
EP3997108A4 EP20836204.6A EP20836204A EP3997108A4 EP 3997108 A4 EP3997108 A4 EP 3997108A4 EP 20836204 A EP20836204 A EP 20836204A EP 3997108 A4 EP3997108 A4 EP 3997108A4
Authority
EP
European Patent Office
Prior art keywords
lipooligosaccharide
vaccines
compositions
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20836204.6A
Other languages
English (en)
French (fr)
Other versions
EP3997108A1 (de
Inventor
J. McLeod GRIFFISS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crapaud Bio Inc
Original Assignee
Crapaud Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crapaud Bio Inc filed Critical Crapaud Bio Inc
Publication of EP3997108A1 publication Critical patent/EP3997108A1/de
Publication of EP3997108A4 publication Critical patent/EP3997108A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP20836204.6A 2019-07-08 2020-07-08 Verfahren zur herstellung und verwendung von lipooligosaccharidzusammensetzungen und impfstoffen Pending EP3997108A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962871472P 2019-07-08 2019-07-08
US201962872973P 2019-07-11 2019-07-11
PCT/US2020/041272 WO2021007365A1 (en) 2019-07-08 2020-07-08 Methods of making and using lipooligosaccharide compositions and vaccines

Publications (2)

Publication Number Publication Date
EP3997108A1 EP3997108A1 (de) 2022-05-18
EP3997108A4 true EP3997108A4 (de) 2024-03-20

Family

ID=74114998

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20836204.6A Pending EP3997108A4 (de) 2019-07-08 2020-07-08 Verfahren zur herstellung und verwendung von lipooligosaccharidzusammensetzungen und impfstoffen

Country Status (6)

Country Link
EP (1) EP3997108A4 (de)
JP (1) JP2022541757A (de)
AU (1) AU2020309556A1 (de)
CA (1) CA3147314A1 (de)
IL (1) IL289690A (de)
WO (1) WO2021007365A1 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568777A1 (de) * 1994-09-26 2005-08-31 The Rockefeller University Deletionsmutante von Neisseria Glycosyltransferase für die Oligosaccharidebiosynthese, und deren Gene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610306B2 (en) * 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
US7261901B2 (en) * 2001-01-31 2007-08-28 University Of Iowa Research Foundation Vaccine and compositions for the prevention and treatment of neisserial infections
WO2002060936A2 (en) * 2001-01-31 2002-08-08 University Of Iowa Research Foundation Vaccine and compositions for the prevention and treatment of neisserial infections
GB0819633D0 (en) * 2008-10-25 2008-12-03 Isis Innovation Composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568777A1 (de) * 1994-09-26 2005-08-31 The Rockefeller University Deletionsmutante von Neisseria Glycosyltransferase für die Oligosaccharidebiosynthese, und deren Gene

Also Published As

Publication number Publication date
JP2022541757A (ja) 2022-09-27
CA3147314A1 (en) 2021-01-14
EP3997108A1 (de) 2022-05-18
AU2020309556A1 (en) 2022-03-03
WO2021007365A1 (en) 2021-01-14
IL289690A (en) 2022-03-01

Similar Documents

Publication Publication Date Title
EP3990562A4 (de) Haftzusammensetzungen und verfahren zur herstellung davon
EP3740576A4 (de) Therapeutische zusammensetzungen und verfahren zur herstellung und verwendung davon
EP3841213A4 (de) Verfahren und zusammensetzungen zur modifizierung von pflanzen
EP3606493A4 (de) Dentalzementzusammensetzungen und verfahren zur verwendung
CA3252800A1 (en) Photodynamic compositions and methods of use
EP3947411A4 (de) Cyclische verbindungen und verfahren zur herstellung und verwendung
EP3740500A4 (de) Zusammensetzungen und verfahren zur erhöhung der expression von scn2a
EP4081047A4 (de) Enzymzusammensetzungen und verfahren zu ihrer herstellung
EP4054514A4 (de) Zusammensetzungen mit fencholen und verfahren zur verwendung
EP4051017A4 (de) Probiotische zusammensetzungen und verfahren
EP4028041A4 (de) Antivirale zusammensetzungen und verfahren zu ihrer herstellung und verwendung
EP3843721A4 (de) Ophthalmische zusammensetzungen und verfahren zur verwendung
EP3997108A4 (de) Verfahren zur herstellung und verwendung von lipooligosaccharidzusammensetzungen und impfstoffen
EP4072544A4 (de) Zusammensetzungen und verfahren zur herstellung von entaromatisierten pfefferkörnern
EP4081233A4 (de) Zusammensetzung und verfahren zur herstellung
HK40082131A (en) Compositions and methods of producing de-flavored peppercorn
AU2019904790A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2019902942A0 (en) Vaccination methods and compositions
HK40065159A (en) Sirt1-sarna compositions and methods of use
AU2018904793A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2019903896A0 (en) Compositions and methods of use
AU2019902527A0 (en) Compositions and methods of use
HK40065278A (en) Nanotransposon compositions and methods of use
AU2020902546A0 (en) Vaccination methods and compositions
HK40084049A (en) Enzyme compositions and methods of making them

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220201

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240216

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/00 20060101ALI20240212BHEP

Ipc: A61P 31/04 20060101ALI20240212BHEP

Ipc: A61K 39/095 20060101ALI20240212BHEP

Ipc: C07K 14/22 20060101AFI20240212BHEP